Yang, Yuxin
Lin, Xiaojin
Chen, Liang
Fan, Yuting
Dou, Xiaowei
Zhang, Jing
Zhang, Yingchun
Liang, Dan
Zhao, Xing
Funding for this research was provided by:
the Guizhou Provincial Health Commission Science and Technology Fund Project (gzwkj2022-087)
the National Natural Science Foundation of China (82060564)
Key Program for Science and Technology of Guizhou Province (ZK (2021)012)
Program for Tumor Immunotherapy Technology Engineering Research Center (University Engineering Center 2024 [001])
Article History
Received: 9 December 2025
Accepted: 19 February 2026
First Online: 6 March 2026
Declarations
:
: Not applicable.
: All authors have approved the final paper for publication.
: The authors declare no competing interests.